Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
THREAD announced a five-year collaboration with, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (...
read more
Thursday, August 31, 2017
Sanofi has selected the Icertis Contract Management (ICM) platform as its contracting foundation.
read more
Monday, December 16, 2019
Sanofi Pasteur has entered into an agreement with the U.S. HHS to increase the company's domestic pandemic influenza vaccine production capabilities.
read more
The EC has licensed Dupixent® for use in adults and adolescents 12 years and older as an add-on maintenance treatment for severe asthma with type 2 inflammation.
read more
Friday, November 06, 2015
Sanofi and Hanmi Pharmaceutical Co., Ltd. have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments
read more
Sanner, a provider of healthcare packaging and drug delivery solutions, officially opened its first U.S.-based production facility in Greensboro, North Carolina.
read more
Wednesday, August 28, 2013
Pharmaceutical contract manufacturer, Sanico NV, has increased tablet inspection at its Turnhout facility in Belgium to 100% with the installation of four INSIGHT PH metal detectors from Lock Inspection Systems. The investment is part of the company...
read more
Wednesday, December 07, 2016
Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
read more
Saneca Pharma has renewed an agreement with Pharmascience for the manufacture and supply of prescription medicines in tablet form.
read more
Thursday, September 22, 2016
Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has added senior talent to its team to position the company for its next phase of growth.
read more
Wednesday, November 09, 2016
Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled release pellets for one of its products.
read more
Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.
read more
Friday, February 16, 2018
CDMO Saneca Pharma has announced the appointment of its new CEO, Richard Král.
read more
Sandoz announced today that Dr. Mark McCamish, Head of Global Biopharmaceutical Development, will present on behalf of the Novartis Group of companies (Novartis) at the May 11 Food and Drug Administration (FDA) public hearing on draft guidances ...
read more
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
read more